PCYT2 and metabolic dysfunction-associated steatohepatitis: In addition, we showed that treatment with the artificial Pcyt2 substrate PEA attenuated several aspects of the Pcyt2 + /- NASH, including lipid accumulation, fibrosis, and the inflammatory response.